Business Description
Telo Genomics Corp
NAICS : 621511
SIC : 8681
ISIN : CA88555C1077
Description
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.94 | |||||
| Equity-to-Asset | 0.08 | |||||
| Debt-to-Equity | 0.89 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -15 | |||||
| 3-Year EPS without NRI Growth Rate | -18.6 | |||||
| 3-Year FCF Growth Rate | -13.4 | |||||
| 3-Year Book Growth Rate | -50.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.08 | |||||
| 9-Day RSI | 44.4 | |||||
| 14-Day RSI | 46.2 | |||||
| 6-1 Month Momentum % | -47.56 | |||||
| 12-1 Month Momentum % | -43.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.99 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.3 | |||||
| Shareholder Yield % | 0.03 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -293.86 | |||||
| ROA % | -216.41 | |||||
| ROIC % | -4648.21 | |||||
| ROC (Joel Greenblatt) % | -6573.23 | |||||
| ROCE % | -290.71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -4.13 | |||||
| EV-to-EBITDA | -4.18 | |||||
| EV-to-FCF | -4.8 | |||||
| Earnings Yield (Greenblatt) % | -24.21 | |||||
| FCF Yield % | -18.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telo Genomics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.028 | ||
| Beta | -1.3 | ||
| Volatility % | 73.19 | ||
| 14-Day RSI | 46.2 | ||
| 14-Day ATR (€) | 0.010018 | ||
| 20-Day SMA (€) | 0.067625 | ||
| 12-1 Month Momentum % | -43.42 | ||
| 52-Week Range (€) | 0.039 - 0.146 | ||
| Shares Outstanding (Mil) | 100.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telo Genomics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telo Genomics Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telo Genomics Corp Frequently Asked Questions
What is Telo Genomics Corp(STU:3D0A)'s stock price today?
The current price of STU:3D0A is €0.06. The 52 week high of STU:3D0A is €0.15 and 52 week low is €0.04.
When is next earnings date of Telo Genomics Corp(STU:3D0A)?
The next earnings date of Telo Genomics Corp(STU:3D0A) is .
Does Telo Genomics Corp(STU:3D0A) pay dividends? If so, how much?
Telo Genomics Corp(STU:3D0A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers